We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Evacetrapib in High-Risk Vascular Disease (ACCELERATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01687998
Recruitment Status : Terminated (Study termination due to insufficient efficacy.)
First Posted : September 19, 2012
Last Update Posted : December 13, 2016
The Cleveland Clinic
Information provided by (Responsible Party):
Eli Lilly and Company